Modern concepts of pain and the opportunities of its overcoming in general medical practice

Authors

DOI:

https://doi.org/10.22141/2224-0713.16.7.2020.218249

Keywords:

pain syndrome, non-steroidal anti-inflammatory drugs, treatment

Abstract

The article presents modern ideas about the mechanisms of pain, clinical manifestations, and its varieties based on the latest published data of the International Association for the Study of Pain (IASP). As the nociceptive type of pain or its combination with neuropathic and nociplastic pain are the most common in clinical practice, the effectiveness of its treatment with non-steroidal anti-inflammatory drugs (NSAIDs) was analyzed, in particular, the modified non-selective cyclooxygenase inhibitor (COX) and its effectiveness in the treatment of acute pain compared to other NSAIDs. Various studies have shown that single and repeated doses of dexketoprofen trometamol provide effective analgesia in the treatment of acute pain of various origins and severity, as well as have favorable safety and tolerance profile that substantiates its widespread use both inpatient and ambulatory, including the use in polymorbid patients.

References

Raja S.N., Carr D.B., Cohen M., et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020. 161(9). 1976-1982. doi: 10.1097/j.pain.0000000000001939.

Treede R.D., Rief W., Barke A., et al. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11). Pain. 2019. 160(1). 19-27. doi: 10.1097/j.pain.0000000000001384.

Woolf C.J. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011. 152(3). 2-15. doi: 10.1016/j.pain.2010.09.030.

Freynhagen R., Parada H.A., Calderon-Ospina C.A., et al. Current understanding of the mixed pain concept: a brief narrative review. Curr. Med. Res. Opin. 2019. 35(6). 1011-1018. doi: 10.1080/03007995.2018.1552042.

Rosenberger D.C., Blechschmidt V., Timmerman H., Wolff A., Treede R.-D. Challenges of neuropathic pain: focus on diabetic neuropathy. Journal of Neural Transmission. 2020. 127(4). 589-624. doi: 10.1007/s00702-020-02145-7.

Жумалиева В.А. Современные представления о патогенезе нейропатической хронической боли. Медицина и экология. 2015. № 4. С. 25-32.

Trouvin A.-P., Perrot S. New concepts of pain. Best Practice & Research Clinical Rheumatology. 2019. 33(3). 101415. doi: 10.1016/j.berh.2019.04.007.

Chimenti R.L., Frey-Law L.A., Sluka K.A. Mechanism-Based Approach to Physical Therapist Management of Pain. Phys. Ther. 2018. 98(5). 302-314. doi: 10.1093/ptj/pzy030.

Соловьева Э.Ю., Карнеев А.Н., Иваноков А.Н., Джутова Э.Д. Декскетопрофен в лечении острой боли в спине. Неврология и психиатрия. 2012. № 5. С. 36-40.

Романенко И.Г., Горобец С.М., Коняева Е.И. и др. Применение нестероидных противовоспалительных лекарственных средств в детской стоматологии. Таврический медико-биологический вестник. 2012. № 15(4). С. 320-323.

Побел Е.А. Сравнительное исследование препарата Дексалгин и других анальгетиков, применяемых для послеоперационного обезболивания. Поликлиника. 2012. № 2. С. 40-42.

Торшин И.Ю., Громова О.А., Федотова Л.Э., Громов А.Н. Сравнительный хемореактомный анализ декскетопрофена, кетопрофена и диклофенака. Неврология, нейропсихиатрия, психосоматика. 2018. № 10(1). С. 47-54. doi:10.14412/2074-2711-2018-1-47-54.

Пилипович А.А. Декскетопрофен: возможности применения в неврологии. Consilium Medicum. 2018. № 20(9). С. 71-75. doi: 10.26442/2075-1753_2018.9.71-75.

Чичасова Н.В. Новые подходы к купированию острого болевого синдрома в ревматологии и неврологии. Consilium Medicum. 2009. № 11(2). С. 50-55.

Пчелинцев М.В. Болевой синдром в онкологии. Возможности применения декскетопрофена. Медицинский совет. 2020. № 9. С. 146-154. doi: 10.21518/2079-701X-2020-9-146-154.

Romero-Alejo E., Puig M.M., Romero A. Antihyperalgesic effects of dexketoprofen and tramadol in a model of postoperative pain in mice — effects on glial cell activation. J. Pharm. Pharmacol. 2016. 68(8). 1041-50. doi: 10.1111/jphp.12584.

Mirandaa H.F., Sierraltab F., Arandab N., Noriegaa V., Prietoa J.C. Pharmacological profile of dexketoprofen in orofacial pain. Pharmacological Reports. 2016. 68(6). 1111-1114. DOI: 10.1016/j.pharep.2017.08.003

Трухан Д.И., Багишева Н.В., Голошубина В.В., Коншу Н.В. Возможности декскетопрофена в лечении болевого синдрома на этапе оказания первичной медико-санитарной помощи. Международный журнал прикладних и фундаментальных исследований. 2017. № 5. С. 263-268.

Moore R.A., Barden J. Systematic review of dexketoprofen in acute and chronic pain. BMC Clin. Pharmacol. 2008. 8. 11. doi: 10.1186/1472-6904-8-11.

Ong C.K.S., Lirk P., Tan C.H., Seymour R.A. An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs. Clinical Medicine & Research. 2007. 5(1). 19-34. doi: 10.3121/cmr.2007.698.

Brzeziński K., Wordliczek J. Comparison of the efficacy of dexketoprofen and diclofenac in treatment of non-specific low back pain. Ann. Agric. Environ. Med. 2013. 1. 52-56.

Anıl A., Kaya F.N., Yavaşcaoğlu B., Efe E.M., Türker G., Demirci A. Comparison of postoperative analgesic efficacy of intraoperative single-dose intravenous administration of dexketoprofen trometamol and diclofenac sodium in laparoscopic cholecystectomy. Journal of Clinical Anesthesia. 2016. 32. 127-133. doi.org/10.1016/j.jclinane.2016.02.020.

Rodriguez M., Contreras D., Galvez R., et al. Double-blind evaluation of short-term analgesic efficacy of orally administered dexketoprofen trometamol and ketorolac in bone cancer pain. Pain. 2003. 104(1–2). 103-110. doi: 10.1016/S0304-3959(02)00470-0.

Sivrikoz N., Koltka K., Güresti E., Büget M., Şentürk M., Özyalçin S. Perioperative dexketoprofen or lornoxicam administration for pain management after major orthopedic surgery: a randomized, controlled study. AĞRI. 2014. 26(1). 23-28. doi: 10.5505/agri.2014.09821

Kesimci E., Gümüş T., İzdeş S., Şen P., Kanbak O. Сomparison of efficacy of dexketoprofen versus paracetamol on postoperative pain and morphine consumption in laminectomy patients. AĞRI. 2011. 23(4). 153-159. doi: 10.5505/agri.2011.86548.

Yang B., Xu Z., Chen L., Chen X., Xie Y. The efficacy of dexketoprofen for migraine attack. A meta-analysis of randomized controlled studies. Medicine. 2019. 98(46). e17734. doi: 10.1097/MD.0000000000017734.

Mainardi F., Maggioni F., Pezzola D., Zava D., Zanchin G. Dexketoprofen Trometamol in the Acute Treatment of Migraine Attack: A Phase II, Randomized, Double-Blind, Crossover, Placebo-Controlled, Dose Optimization Study. The Journal of Pain. 2014. 15(4). 388-394. doi: 10.1016/j.jpain.2013.12.006.

Gungor F., Akyol K.C., Kesapli M., et al. Intravenous dexketoprofen vs placebo for migraine attack in the emergency department: A randomized, placebo-controlled trial. Cephalalgia. 2016. 36(2). 179-184. doi: 10.1177/0333102415584604.

Andrew Moore1 R., Gay-Escoda C., Figueiredo R., et al. Dexketoprofen/tramadol: randomised double-blind trial and confirmation of empirical theory of combination analgesics in acute pain. The Journal of Headache and Pain. 2015. 16. 60. doi 10.1186/s10194-015-0541-5.

Varrassi G., Hanna M., Macheras G., et al. Multimodal ­analgesia in moderate-to-severe pain: a role for a new fixed combination of dexketoprofen and tramadol. Curr. Med. Res. Opin. 2017. 33(6). 1165-1173. doi: 10.1080/03007995.2017.1310092.

Laporte J-R., Ibáñez L., Vidal X., Vendrell L., Leone R. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf. 2004. 27(6). 411-20. doi: 10.2165/00002018-200427060-00005.

Carne X, Rios J., Torres F. Postmarketing cohort study to assess the safety profile of oral dexketoprofen trometamol for mild to mode-

rate acute pain treatment in primary care. Methods and Findings in Experimental and Clinical Pharmacology. 2009. 31(8). 533-40. doi: 10.1358/mf.2009.31.8.1419070.

Rey-Matias R.R., Leochico C.F.D., Nilo G.S. Effectiveness and Safety of Oral Dexketoprofen for Mild to Moderate Pain among Filipino Adults: A Post-marketing Surveillance Study. J. Pain Relief. 2018. 7. 319. doi: 10.4172/2167-0846.1000319.

Hanna M., Moon J.Y. A review of dexketoprofen trometamol in acute pain. Current Medical Research and Opinion. 2019. 35(2). 189-202. doi: 10.1080/03007995.2018.1457016.

Каймак Т.В., Калиева А.К., Оспанов Б.Т., Чайко В.И., Ишмухаметов Р.Ш. Боль в спине: купирование острых болевых синдромов поясничной области вертеброгенного генеза. Mедицина. 2013. № 11. С. 53-56.

Плотникова Е.Ю., Золотухина В.Н., Исаков Л.К. и др. Эффективность и безопасность различных нестероидных противовоспалительных препаратов при острой боли в шее и спине. Неврология, нейропсихиатрия, психосоматика. 2020. № 12(2). С. 42-47. doi: 10.14412/2074-2711-2020-2-42-47.

Zippel H., Wagenitz A. multicentre, randomised, double-blind study comparing the efficacy and tolerability of intramuscular dexketoprofen versus diclofenac in the symptomatic treatment of acute low back pain. Clin. Drug Investig. 2007. 27(8). 533-43. doi: 10.2165/00044011-200727080-00002.

Published

2020-10-01

Issue

Section

To practicing Neurologist